These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 6174222)

  • 21. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon induced in human leukocytes by mitogens: production, partial purification and characterization.
    de Ley M; van Damme J; Claeys H; Weening H; Heine JW; Billiau A; Vermylen C; de Somer P
    Eur J Immunol; 1980 Nov; 10(11):877-83. PubMed ID: 6161829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
    Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
    Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natural killer cells lysing the blood B-lymphocytes of patients with chronic lympholeukemia].
    Khonina NA; Shubinskiĭ GZ
    Eksp Onkol; 1988; 10(4):44-6. PubMed ID: 3263265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of stimulation of natural killer-cell cytotoxicity by interferon and an interferon-inducer in the rat.
    Flexman JP; Shellam GR
    Immunology; 1981 Oct; 44(2):311-20. PubMed ID: 6170575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
    Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
    Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-interferon structure and natural killer cell stimulatory activity.
    Li BL; Zhao XX; Liu XY; Kim HS; Raska K; Ortaldo JR; Schwartz B; Pestka S
    Cancer Res; 1990 Sep; 50(17):5328-32. PubMed ID: 2201435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined effects of immunity and antitumor drugs against cancer. II. In vitro studies with cis-diamminedichloroplatinum in a human leukemia system.
    De Filippi R; Fuggetta MP; Ricci F; Marini S; Caliendo R; Giuliani A
    Chemioterapia; 1987 Dec; 6(6):410-6. PubMed ID: 2449291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
    Gray JD; Torten M; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
    Horwitz DA; Bakke AC; Abo W; Nishiya K
    J Immunol; 1984 May; 132(5):2370-4. PubMed ID: 6201542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity.
    Ortaldo JR; Phillips W; Wasserman K; Herberman RB
    J Immunol; 1980 Oct; 125(4):1839-44. PubMed ID: 6157747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
    Golub SH; D'Amore P; Rainey M
    J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
    Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
    J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effector cell sensitivity to sugar moieties. II. Inhibition by monosaccharides of interferon enhanced human natural killing.
    Ades EW; Hinson A
    J Clin Lab Immunol; 1983 Aug; 11(4):173-6. PubMed ID: 6199501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.